{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T04:04:23Z","timestamp":1791691463618,"version":"4.3.4"},"reference-count":40,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Pretreatment with \u03b1-adrenergic receptor blockers is recommended to prevent hemodynamic instability during resection of a pheochromocytoma or sympathetic paraganglioma (PPGL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine which type of \u03b1-adrenergic receptor blocker provides the best efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Randomized controlled open-label trial (PRESCRIPT; ClinicalTrials.gov NCT01379898)<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Multicenter study including 9 centers in The Netherlands.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>134 patients with nonmetastatic PPGL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Phenoxybenzamine or doxazosin starting 2 to 3 weeks before surgery using a blood pressure targeted titration schedule. Intraoperative hemodynamic management was standardized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>Primary efficacy endpoint was the cumulative intraoperative time outside the blood pressure target range (ie, SBP &amp;gt;160 mmHg or MAP &amp;lt;60 mmHg) expressed as a percentage of total surgical procedure time. Secondary efficacy endpoint was the value on a hemodynamic instability score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median cumulative time outside blood pressure targets was 11.1% (interquartile range [IQR]: 4.3\u201320.6] in the phenoxybenzamine group compared to 12.2% (5.3\u201320.2)] in the doxazosin group (P = .75, r = 0.03). The hemodynamic instability score was 38.0 (28.8\u201358.0) and 50.0 (35.3\u201363.8) in the phenoxybenzamine and doxazosin group, respectively (P = .02, r = 0.20). The 30-day cardiovascular complication rate was 8.8% and 6.9% in the phenoxybenzamine and doxazosin group, respectively (P = .68). There was no mortality after 30 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The duration of blood pressure outside the target range during resection of a PPGL was not different after preoperative treatment with either phenoxybenzamine or doxazosin. Phenoxybenzamine was more effective in preventing intraoperative hemodynamic instability, but it could not be established whether this was associated with a better clinical outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgz188","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T09:38:38Z","timestamp":1573551518000},"page":"2381-2391","source":"Crossref","is-referenced-by-count":140,"title":["Efficacy of \u03b1-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial"],"prefix":"10.1210","volume":"105","author":[{"given":"Edward","family":"Buitenwerf","sequence":"first","affiliation":[{"name":"Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamara E","family":"Osinga","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri J L M","family":"Timmers","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques W M","family":"Lenders","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section of Vascular Medicine, Radboud University Medical Center, Nijmegen, The Netherlands"},{"name":"Department of Medicine III, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Feelders","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section of Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth M W","family":"Eekhoff","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Endocrinology Section, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm R","family":"Haak","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, M\u00e1xima Medical Center, Eindhoven, The Netherlands"},{"name":"Department of Internal Medicine, Division of General Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands"},{"name":"Maastricht University, CAPHRI School for Public Health and Primary Care, Ageing and Long-Term Care, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora P M","family":"Corssmit","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H L T","family":"Bisschop","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlof D","family":"Valk","sequence":"additional","affiliation":[{"name":"Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald Groote","family":"Veldman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Medical Spectrum Twente, Enschede, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin P F","family":"Dullaart","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thera P","family":"Links","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magiel F","family":"Voogd","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6tz J K G","family":"Wietasch","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel N","family":"Kerstens","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"2021122116321341500_CIT0001","volume-title":"Pathology and Genetics: Tumours of Endocrine Organs (IARC WHO Classification of Tumours)","author":"DeLellis","year":"2004"},{"issue":"3","key":"2021122116321341500_CIT0002","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1210\/jc.2012-3669","article-title":"Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines?","volume":"98","author":"Stolk","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122116321341500_CIT0003","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-0032-1306294","article-title":"High incidence of cardiovascular complications in pheochromocytoma","volume":"44","author":"Zelinka","year":"2012","journal-title":"Horm Metab Res."},{"issue":"11","key":"2021122116321341500_CIT0004","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/HJH.0b013e32834a4ce9","article-title":"Cardiovascular manifestations of phaeochromocytoma","volume":"29","author":"Prejbisz","year":"2011","journal-title":"J Hypertens."},{"issue":"6","key":"2021122116321341500_CIT0005","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021122116321341500_CIT0006","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/00000542-195411000-00009","article-title":"Pheochromocytoma; surgical and anesthetic management","volume":"15","author":"Thompson","year":"1954","journal-title":"Anesthesiology."},{"issue":"5534","key":"2021122116321341500_CIT0007","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/bmj.1.5534.191","article-title":"Preoperative and operative management of patients with phaeochromocytoma","volume":"1","author":"Ross","year":"1967","journal-title":"Br Med J."},{"issue":"1","key":"2021122116321341500_CIT0008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1213\/00000539-199901000-00004","article-title":"Hemodynamic changes and catecholamine release during laparoscopic adrenalectomy for pheochromocytoma","volume":"88","author":"Joris","year":"1999","journal-title":"Anesth Analg."},{"issue":"13","key":"2021122116321341500_CIT0009","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1245\/s10434-015-4519-y","article-title":"Hemodynamic stability during pheochromocytoma resection: lessons learned over the last two decades","volume":"22","author":"Livingstone","year":"2015","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"2021122116321341500_CIT0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/jc.2009-1051","article-title":"Risk factors for hemodynamic instability during surgery for pheochromocytoma","volume":"95","author":"Bruynzeel","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122116321341500_CIT0011","first-page":"191","article-title":"Alpha blockade in preoperative preparation of patients with pheochromocytomas","volume":"87","author":"Kocak","year":"2002","journal-title":"Int Surg."},{"issue":"8","key":"2021122116321341500_CIT0012","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00268-002-6667-z","article-title":"Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma","volume":"26","author":"Prys-Roberts","year":"2002","journal-title":"World J Surg."},{"issue":"2","key":"2021122116321341500_CIT0013","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12020-010-9381-x","article-title":"Selective \u03b11-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma","volume":"38","author":"Zhu","year":"2010","journal-title":"Endocrine."},{"issue":"2","key":"2021122116321341500_CIT0014","doi-asserted-by":"crossref","first-page":"508.e6","DOI":"10.1016\/j.urology.2010.03.032","article-title":"Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma","volume":"76","author":"Weingarten","year":"2010","journal-title":"Urology."},{"issue":"2","key":"2021122116321341500_CIT0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00540-018-2447-2","article-title":"Vasoactive-inotropic score as a predictor of morbidity and mortality in adults after cardiac surgery with cardiopulmonary bypass","volume":"32","author":"Yamazaki","year":"2018","journal-title":"J Anesth."},{"issue":"6","key":"2021122116321341500_CIT0016","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/SLA.0000000000002220","article-title":"Effects of intraoperative fluid management on postoperative outcomes: a hospital registry study","volume":"267","author":"Shin","year":"2018","journal-title":"Ann Surg."},{"issue":"4","key":"2021122116321341500_CIT0017","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/EJA.0000000000000941","article-title":"The haemodynamic instability score: Development and internal validation of a new rating method of intra-operative haemodynamic instability","volume":"36","author":"Buitenwerf","year":"2019","journal-title":"Eur J Anaesthesiol."},{"issue":"11","key":"2021122116321341500_CIT0018","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med."},{"issue":"9","key":"2021122116321341500_CIT0019","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1373\/clinchem.2007.087114","article-title":"Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry","volume":"53","author":"de Jong","year":"2007","journal-title":"Clin Chem."},{"issue":"11","key":"2021122116321341500_CIT0020","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1210\/jc.2007-1720","article-title":"Preoperative management of the pheochromocytoma patient","volume":"92","author":"Pacak","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122116321341500_CIT0021","author":"Buitenwerf"},{"key":"2021122116321341500_CIT0022","author":"National Cancer Institute"},{"key":"2021122116321341500_CIT0023","first-page":"231","article-title":"Parametric measures","volume-title":"The Handbook of Research Synthesis","author":"Rosenthal","year":"1994"},{"issue":"16","key":"2021122116321341500_CIT0024","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jama.1949.82900510003006a","article-title":"Treatment of a patient with a pheochromocytoma; use of an adrenolytic drug before and during operation","volume":"140","author":"Grimson","year":"1949","journal-title":"J Am Med Assoc."},{"key":"2021122116321341500_CIT0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1353.001","article-title":"An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges","volume":"1073","author":"Manger","year":"2006","journal-title":"Ann N Y Acad Sci."},{"issue":"7","key":"2021122116321341500_CIT0026","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3949\/ccjm.57.7.613","article-title":"Perioperative management of 63 patients with pheochromocytoma","volume":"57","author":"Boutros","year":"1990","journal-title":"Cleve Clin J Med."},{"issue":"3","key":"2021122116321341500_CIT0027","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/ALN.0b013e3182a10e26","article-title":"Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension","volume":"119","author":"Walsh","year":"2013","journal-title":"Anesthesiology."},{"issue":"1","key":"2021122116321341500_CIT0028","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/ALN.0000000000000922","article-title":"Association between intraoperative hypotension and myocardial injury after vascular surgery","volume":"124","author":"van Waes","year":"2016","journal-title":"Anesthesiology."},{"issue":"3","key":"2021122116321341500_CIT0029","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/ALN.0000000000000765","article-title":"Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery","volume":"123","author":"Sun","year":"2015","journal-title":"Anesthesiology."},{"issue":"1","key":"2021122116321341500_CIT0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/ALN.0000000000000686","article-title":"Intraoperative mean arterial pressure variability and 30-day mortality in patients having noncardiac surgery","volume":"123","author":"Mascha","year":"2015","journal-title":"Anesthesiology."},{"issue":"14","key":"2021122116321341500_CIT0031","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1001\/jama.2017.14172","article-title":"Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial","volume":"318","author":"Futier","year":"2017","journal-title":"JAMA."},{"key":"2021122116321341500_CIT0032","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","article-title":"Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review","volume":"51","author":"Berends","year":"2018","journal-title":"Eur J Intern Med."},{"issue":"12","key":"2021122116321341500_CIT0033","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1245\/s10434-014-3847-7","article-title":"Predictors of hemodynamic instability during surgery for pheochromocytoma","volume":"21","author":"Kiernan","year":"2014","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"2021122116321341500_CIT0034","first-page":"1480","article-title":"Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center","volume":"86","author":"Plouin","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122116321341500_CIT0035","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/archsurg.1951.01250030644004","article-title":"Pheochromocytoma. Anesthetic management during surgical treatment","volume":"62","author":"Apgar","year":"1951","journal-title":"AMA Arch Surg."},{"issue":"11","key":"2021122116321341500_CIT0036","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/EJA.0000000000000844","article-title":"The role of pre-operative \u03b1-blockade in patients with normotensive phaeochromocytoma or paraganglioma: A retrospective cohort study","volume":"35","author":"Kong","year":"2018","journal-title":"Eur J Anaesthesiol."},{"issue":"2","key":"2021122116321341500_CIT0037","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/bja\/aew392","article-title":"Perioperative \u03b1-receptor blockade in phaeochromocytoma surgery: an observational case series","volume":"118","author":"Groeben","year":"2017","journal-title":"Br J Anaesth."},{"issue":"3","key":"2021122116321341500_CIT0038","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/cen.13284","article-title":"Preoperative alpha-blockade in phaeochromocytoma and paraganglioma: is it always necessary?","volume":"86","author":"Isaacs","year":"2017","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1","key":"2021122116321341500_CIT0039","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4158\/EP-2018-0455","article-title":"WHY take the risk? we only live once: the dangers associated with neglecting a pre-operative alpha adrenoceptor blockade in pheochromocytoma patients","volume":"25","author":"Wolf","year":"2019","journal-title":"Endocr Pract."},{"issue":"2","key":"2021122116321341500_CIT0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ncpendmet0396","article-title":"Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005","volume":"3","author":"Pacak","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgz188\/30665626\/dgz188.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/7\/2381\/41840914\/jcem_105_7_2381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/7\/2381\/41840914\/jcem_105_7_2381.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T12:07:48Z","timestamp":1640088468000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/7\/2381\/5622983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,11,12]]},"published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgz188","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2019,11,12]]}}}